Your account is not claimed yet. You can sign up with ORCID to claim your account.

Gustavo Henrique Goulart Trossini

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

Future medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

Chemical biology & drug design

Journal of biomolecular structure & dynamics

Universidade de São Paulo Faculdade de Ciências Farmacêuticas

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade de São Paulo Faculdade de Ciências Farmacêuticas Apr 7o 2011

Brazil

Professor :: Farmácia

Publications

Rafael Bello Gonçalves, Witor Ribeiro Ferraz, Raisa Ludmila Calil, Marcus Tullius Scotti, Gustavo Henrique Goulart Trossini
Convergent QSAR Models for the Prediction of Cruzain Inhibitors. ACS omega 8 (42) (2023)
André Berndt Penteado, Haifa Hassanie, Renan Augusto Gomes, Flavio da Silva Emery, Gustavo Henrique Goulart Trossini
Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future medicinal chemistry 15 (3) (2023)
Glaucio Monteiro Ferreira, Thales Kronenberger, Vinícius Gonçalves Maltarollo, Antti Poso, Fernando de Moura Gatti, Vitor Medeiros Almeida, Sandro Roberto Marana, Carla Duque Lopes, Daiane Yukie Tezuka, Sérgio de Albuquerque, Flavio da Silva Emery, Gustavo Henrique Goulart Trossini
Trypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Glaucio Monteiro Ferreira, Thales Kronenberger, Vinícius Gonçalves Maltarollo, Antti Poso, Fernando de Moura Gatti, Vitor Medeiros Almeida, Sandro Roberto Marana, Carla Duque Lopes, Daiane Yukie Tezuka, Sérgio de Albuquerque, Flavio da Silva Emery, Gustavo Henrique Goulart Trossini
Trypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
André Berndt Penteado, Haifa Hassanie, Renan Augusto Gomes, Flavio da Silva Emery, Gustavo Henrique Goulart Trossini
Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future medicinal chemistry (2023)
Glaucio Monteiro Ferreira, Thales Kronenberger, Vinícius Gonçalves Maltarollo, Antti Poso, Fernando de Moura Gatti, Vitor Medeiros Almeida, Sandro Roberto Marana, Carla Duque Lopes, Daiane Yukie Tezuka, Sérgio de Albuquerque, Flavio da Silva Emery, Gustavo Henrique Goulart Trossini
Trypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
André Berndt Penteado, Haifa Hassanie, Renan Augusto Gomes, Flavio da Silva Emery, Gustavo Henrique Goulart Trossini
Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future medicinal chemistry 15 (3) (2023)
Gustavo Henrique Marques Sousa, Renan Augusto Gomes, Eliseu Ortega de Oliveira, Gustavo Henrique Goulart Trossini
Machine learning methods applied for the prediction of biological activities of triple reuptake inhibitors. Journal of biomolecular structure & dynamics (2022)
Renan Augusto Gomes, Evelin Fornari, Ana Carolina Silva Rocha, Gustavo Luis Tripodi, Flavio da Silva Emery, Gustavo Henrique Goulart Trossini
Parasitic sirtuin 2 as an opportunity in drug discovery. Future medicinal chemistry 13 (16) (2021)
Witor Ribeiro Ferraz, Renan Augusto Gomes, Andre Luis S Novaes, Gustavo Henrique Goulart Trossini
Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study. Future medicinal chemistry 12 (20) (2020)
Fernando de Moura Gatti, Renan Augusto Gomes, Amanda Luisa da Fonseca, Elys Juliane Cardoso Lima, Drielli Gomes Vital-Fujii, Alex Guterres Taranto, Fernando de Pilla Varotti, Gustavo Henrique Goulart Trossini
Antiplasmodial activity of sulfonylhydrazones: in vitro and in silico approaches. Future medicinal chemistry 13 (3) (2020)
Kamila Anna Meissner, Thales Kronenberger, Vinícius Gonçalves Maltarollo, Gustavo Henrique Goulart Trossini, Carsten Wrenger
Targeting the Plasmodium falciparum plasmepsin V by ligand-based virtual screening. Chemical biology & drug design 93 (3) (2018)
Juliana da Fonseca Rezende E Mello, Renan Augusto Gomes, Drielli Gomes Vital-Fujii, Glaucio Monteiro Ferreira, Gustavo Henrique Goulart Trossini
Fragment-based drug discovery as alternative strategy to the drug development for neglected diseases. Chemical biology & drug design 90 (6) (2017)

Gustavo Henrique Goulart Trossini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gustavo Henrique Goulart Trossini